1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow ammonul: new trials by email Literature Review of ammonul trials Research Report on ammonul
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy sodium phenylacetate and sodium benzoate injection 10% / 10%, placebo solution (10% dextrose) - Hepatic Encephalopathy | Phase 2 | Terminated | Amgen | 1 | 2007-12-01 | 2024-12-17 |
| A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P) HPN-100, Ammonul, Buphenyl - Healthy | Phase 1 | Completed | Amgen | 24 | 2005-03-01 | 2024-06-20 |
Hepatic Encephalopathy (1) · Lymphoma, Follicular (1)
Amgen (2)
Ukraine (1) · United States (1)